Both in Pharmaceuticals
Kura Oncology vs Geron
Over the past year KURA returned −16.8% and GERN returned −13.8%; their daily moves had a correlation of 0.19.
KURA −16.8% GERN −13.8%Growth of $1, one year, split-adjusted
| Metric | KURA | GERN |
|---|---|---|
| Price | $8.13 | $1.04 |
| Market cap | $723.2M | $665.0M |
| Today | −17.71% | +11.29% |
| 1 month | −22.8% | −14.5% |
| 6 months | −15.0% | −34.5% |
| Year to date | −21.8% | −21.6% |
| 1 year | −16.8% | −13.8% |
| Revenue growth (YoY) | +36.5% | +17.2% |
| Gross margin | 98.8% | 83.9% |
| Net margin | −327.3% | −29.0% |
| P/E (TTM) | — | — |
| Price / sales | 9.4× | 3.3× |
| Net cash | $509.2M | $51.1M |
| Dividend yield | — | — |
| Volatility (60d) | 68.4% | 60.7% |
| Short % of float | 18.3% | 11.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).